Shutdown Puts FDA Food Inspections and Drug Reviews at Risk
This article is for subscribers only.
The head of the U.S. Food and Drug Administration said that a government shutdown would prevent the agency from doing some routine food-safety inspections, and that the agency is weeks away from running out of funds it uses to review new drugs and medical products.
“The functions that can most directly impact consumer safety will continue, to the best of our abilities, subject to the legal and financial limitations of the current circumstances,” FDA Commissioner Scott Gottlieb said in a tweet Tuesday.